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Schwannomas are generally slow growing asymptomatic neoplasms that rarely occur in the GI tract. However, if found, the most
common site is the stomach. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the
gastrointestinal tract, and 60–70% of them occur in the stomach. Owing to their typical presentation as submucosal neoplasms,
gastric schwannomas and GISTs appear grossly similar. Accordingly, the differential diagnosis for a gastric submucosal mass
should include gastric schwannomas. Furthermore, GI schwannomas are benign neoplasms with excellent prognosis after surgical
resection, whereas 10–30% of GISTs have malignant behavior. Hence, it is important to distinguish gastric schwannomas from
GISTs to make an accurate diagnosis to optimally guide treatment options. Nevertheless, owing to the paucity of gastric schwan-
nomas, the index of suspicion for this diagnosis is low. We report a rare case of gastric schwannoma in 53-year-old woman who
underwent laparoscopic partial gastrectomy under the suspicion of a GIST preoperatively but confirmed to have a gastric schwan-
noma postoperatively. This case underscores the importance of including gastric schwannomas in the differential diagnosis when
preoperative imaging studies reveal a submucosal, exophytic gastric mass. For a gastric schwannoma, complete margin negative
surgical resection is the curative treatment of choice.
1. Introduction
Mesenchymal tumors of the gastrointestinal (GI) tract are
mainly comprised of a spectrum of spindle cell tumors which
include gastrointestinal stromal tumors (GISTs), leiomyomas
or leiomyosarcomas, and schwannomas [1]. Among these
neoplasms, GISTs are the most common and a great majority
(60–70%) of them occur in the stomach [2, 3]. Schwanno-
mas, contrastingly, are generally slow growing asymptomatic
neoplasms that rarely occur in the GI tract. However, if
found, the most common site is the stomach, accounting
for 0.2% of all gastric tumors [4, 5]. Accordingly, the main
differential diagnosis of a gastric schwannoma is a GIST.
Owing to their typical presentation as submucosal neo-
plasms with spindle cell histology, gastric schwannomas and
GISTs appear grossly similar [2, 6]. Both gastric schwanno-
mas and GISTs occur predominantly in middle-aged persons
[1, 5]. They also appear to have no distinct clinical features
[1, 4, 7]. However, the prognosis for gastric schwannomas
and GISTs is very different. As reported by Daimaru et al.,
in 1988, gastric schwannomas are benign tumors with an
excellent prognosis [5, 6, 8], whereas 10–30% of GISTs have
malignant behavior [1, 2, 9]. Hence, it is important to make
an accurate diagnosis to optimally guide treatment options.
Nonetheless, a diagnostic difficulty exists in that preop-
erative conventional imaging techniques (i.e., sonography,
endoscopy, and computed tomography), although helpful,
cannot always provide enough information to differentiate
between these two tumors. Indeed, radiologic and endo-
scopic findings are nonspecific [8, 10]. Furthermore, owing
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Figure 1: Transabdominal sonogram reveals a round and well-defined mass in the stomach.
to the rarity of gastric schwannomas, there is limited data in
the medical literature about the imaging appearance of this
neoplasm. Ultimately, the definitive diagnoses of GISTs and
gastric schwannomas require immunohistochemical studies
which only can be performed on the surgical specimen.
In this paper, we present a 53-year-old woman with a gas-
tric mass who underwent laparoscopic partial gastrectomy
under the suspicion of a GIST preoperatively but confirmed
to have a gastric schwannoma postoperatively.
2. Case Report
A 53-year-old woman was referred to surgical oncology for
a gastric mass. The reason for her initial visit was chest
pain. She only complained of intermittent gastric discomfort
and dysphagia in response to solids. Her medical history
was significant for hypertension, hyperlipidemia, diabetes
mellitus, hypothyroidism, and uterine cancer, which was
successfully treated with robotic hysterectomy 5 years prior.
During the chest pain assessment, a gastric mass was
incidentally detected on abdominal ultrasound (Figure 1). A
subsequent contrast-enhanced CT scan showed a homoge-
nous exophytic mass, measuring 4.8× 4.2× 3.6 cm and aris-
ing from the antrum of the stomach (Figure 2). The overlying
mucosa was smooth with a few minute calcifications. There
was no evidence of any other abnormalities.
The patient then underwent an esophagogastroduo-
denoscopy (EGD), and a submucosal mass lesion was con-
firmed in the gastric antrum with normal overlying gastric
mucosa. Biopsy specimens obtained at the endoscopy yielded
only unspecific signs of mild inactive chronic inflamma-
tion without evidence of a malignancy. To facilitate the
evaluation, we performed an endoscopic ultrasound (EUS)
examination, which depicted a hypoechoic heterogeneous
mass lesion with calcifications located in the gastric antrum
(Figure 3). The mass had cystic spaces and appeared to arise
from the muscularis propria, and there was no perigastric
lymphadenopathy. EUS-guided fine needle aspiration (FNA)
was then performed. The aspirate smears showed rare
spindle cell tissue fragments with bland cytomorphological
features. These findings appeared most consistent with a
GIST.
After presenting the case at our GastrointestinalMultidis-
ciplinary Tumor Board Conference, a consensus was reached
to proceed with resection. The patient was counseled about
(a)
(b)
Figure 2: Contrast-enhanced CT showing a round, well-defined,
and homogeneously enhancing mass arising from the antrum of the
stomach.
the surgical options and offered an elective laparoscopic
partial gastrectomy. After informed consent was obtained,
the patient was taken to the operating room where she was
placed in the supine position under general endotracheal
anesthesia. The abdomen was prepped and draped in sterile
fashion. Pneumoperitoneum was achieved at 15 millime-
ters of mercury, and four additional trocars were placed
under direct vision as shown in Figure 4. The stomach was
mobilized by opening the gastrocolic ligament. Following
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Figure 3: Endoscopic ultrasonogram: a 5 cm hypoechoic inhomo-
geneous mass lesion with calcification is seen. The mass appears to
arise from the muscularis propria.
Figure 4: Schematic diagram showing trocar positions: three 5mm
trocars (right subcostal, subxiphoid, left lateral), one 10mm trocar
(left subcostal), and one 15mm trocar (supraumbilical) are used.
mobilization of the greater curve, we clearly identified a large
exophytic mass along the greater curve in the gastric antrum
close to the pylorus. We isolated the mass from the stomach
and actually suspended the mass from the stomach with
laparoscopic Babcock atraumatic graspers (Figure 5). Due to
the close proximity of the mass to the pylorus, we placed a
32-Fr boogie in the stomach and then used an endovascular
gastrointestinal anastomosis (GIA) stapler across the base of
the mass in viable stomach ensuring a negative margin. We
then retrieved the specimen (the mass with a portion of the
stomach) through an endocatch bag through the supraum-
bilical port and sent to pathology for analysis. The rest of the
abdominal cavity was visualized, and there was no other
evidence of abnormalities. The patient had a brief uneventful
recovery.
The final pathologic study revealed that the resected
neoplastic mass was comprised of spindle cells of varying
cellularity with relatively bland cytology and focal nuclear
palisading (Figure 6(a)). There was lymphocytic cuffing at
the periphery of the tumor (Figure 6(b)). The neoplastic
cells were immunoreactive with S-100 protein (Figure 7),
but lacked immunoreactivity with CD 117 (Figure 8(a)),
CD 34 (Figure 8(b)), smooth-muscle actin and desmin.
Figure 5: Macroscopic inspection during laparoscopic surgery
shows a large exophytic mass along the greater curve in the antrum
of the stomach.
(a)
(b)
Figure 6: (a) Spindle cell proliferation with relatively bland cyto-
logy and focal nuclear palisading (arrow) (H&E, ×200); (b) lym-
phocytic cuffing (arrow) at the peripheral part of the tumor is a
common feature (H&E, ×100).
Figure 7: The tumor cells are positive for S-100 protein (immunos-
taining of S-100 protein, ×200).
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(a) (b)
Figure 8: The tumor cells are negative for CD 117 immunostain ((a) ×200) and CD 34 immunostain ((b) ×200).
The histopathologic features and immunohistochemical
staining pattern were consistent with a gastric schwannoma.
3. Discussion
Schwannomas, also known as neurilemmomas or neuri-
nomas, are benign neurogenic tumors, originating from
Schwann cells, which normally wrap around the axons of the
peripheral nerves. Theoretically, schwannomas can develop
anywhere along the peripheral course of nerve. However,
they most commonly occur in the head and neck but rarely
in the GI tract [11].
Gastric schwannomas, the most common GI schwan-
noma, account only for 0.2% of all gastric tumors, and
principally involve the submucosa and muscularis propria
[4–6]. They grow slowly and exophytically and are usually
asymptomatic. Because of this indolent growth pattern, as
with our case, these tumors often discovered incidentally
via cross-sectional imaging or endoscopy [8, 11]. If symp-
tomatic, the most common presenting symptom is upper GI
bleeding, which may be secondary to the growing submu-
cosal mass compromising the blood supply to the overlying
mucosa. The mucosa overlying the mass may then ulcerate
secondary to ischemia or from a reduced tolerance to the
gastric acidity [4, 10, 11].
For a gastric submucosal mass, the main differential
diagnosis is a GIST. Although rare, gastric schwannomas are
also a primary GI mesenchymal tumor [6]. Most impor-
tantly, all published data to date indicate that GI schwan-
nomas are benign neoplasms with excellent prognosis after
surgical resection [5, 6, 8]. Therefore, the differential diag-
nosis for a gastric submucosal mass should include gastric
schwannomas, for it is important to distinguish gastric
schwannomas from GISTs. Nevertheless, owing to the pau-
city of cases, the index of suspicion for this diagnosis is low.
The differentiation between gastric schwannomas and
GISTs can be difficult preoperatively. While preoperative
imaging studies, such as sonography, endoscopy, and CT, can
demonstrate the presence or extent of invasion, none of these
modalities have shown any distinct features unique to these
neoplasms [10–13]. Furthermore, due to the rarity of gastric
schwannomas, there is limited data in the medical literature
about the imaging features of this neoplasm.
In 2005, Levy et al. reported that gastric schwannomas
are uniquely different from other schwannomas in that they
show homogeneous attenuation on CT and that degenerative
changes such as cystic changes are uncommon [12]. In
addition, they suggested that the homogenous enhancement
pattern may aid in differentiation of gastric schwannomas
from GISTs, which frequently show heterogeneous enhance-
ment due to degenerative changes. Later, in 2008, Hong et al.
reported similar findings after studying 16 cases of gastric
schwannomas at their institution: 13 cases showed a homo-
geneous enhancement pattern (81%), and cystic changes
were seen in 2 cases (13%) [13]. Our case, which was immu-
nohistochemically diagnosed as a gastric schwannoma post-
operatively, had uncommon cystic changes and did not
enhance intensely, although appeared as a homogeneous
mass.
Consistent with the CT findings, endoscopic ultrasono-
gram of our case depicted a heterogeneously hypoechoic
mass. It seemed that the cystic changes caused inhomoge-
neous echoes, and the dense composition of spindle cells
caused the lower echogenicity [10]. Endoscopic tissue biop-
sies also yielded inconclusive results. As shown in this case,
endoscopic biopsymay not be adequate for definite diagnosis
because mucosal abnormalities are rarely observed in these
submucosal tumors [8, 11].
Despite strong morphological similarities, GI mesenchy-
mal tumors are heterogeneous in their immunophenotypes.
In the past, gastric schwannomas were included in the GIST
category [6]. In 1988, Daimaru et al. successfully identified
schwannoma as a primary GI tumor based on the positive
S-100 stain [5, 6]. GIST also became a distinct GI cancer
diagnostic category when it was discovered that nearly all
GIST cells express c-kit protein [1, 2]. Before the recognition
of S-100 antigen and c-kit antigen in gastric schwannomas
and in GISTs, respectively, these neoplasms were most often
classified as leiomyoma, leiomyosarcoma, or gastrointestinal
autonomic nerve tumor [1, 2, 5, 6]. With the advent of
immunohistochemical staining techniques and ultrastruc-
tural evaluation, it is now possible to identify these neo-
plasms based on their distinct immunophenotypes. Gastric
Case Reports in Surgery 5
schwannomas are positive for S-100 protein and negative for
c-kit; conversely, GISTs are positive for c-kit and negative for
S-100 protein. Our case fulfilled the immunohistochemical
diagnosis for a gastric schwannoma.
In summary, this case underscores the importance of
including gastric schwannomas in the differential diagnosis
when preoperative imaging studies reveal a submucosal, exo-
phytic gastric mass. Thus far, the majority of previous series
in the literature addressing gastric schwannomas regard these
neoplasms as uniformly slow growing benign tumors. Owing
to subclinical tumor growth, the diagnosis is usually delayed.
However, to date, there is no clear evidence in the literature to
suggest that gastric schwannomas have malignant potential.
Additionally, recurrent disease has been only observed after
incomplete resection [4–6]. Therefore, when diagnosed or
suspected, complete margin negative surgical resection, as in
this case, is the curative treatment of choice.
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